Literature DB >> 1864002

New Zealand black mice are immunologically resistant to high-dose, but not low-dose Leishmania mexicana infection.

R C Dorea1, J Alexander, G Gallagher.   

Abstract

The course of infection following s.c. inoculation of a wide dose range of L. mexicana stationary-phase promastigotes (SPP) was examined in sexually mature and immature NZB mice of both sexes. Infection with a high dose (greater than 10(7) SPP) was able to induce a protective in vivo response, which could be adoptively transferred with parasite-immune T cells, into naive, syngeneic recipients. In contrast, s.c. infection with a low dose (less than 10(7) SPP) induced non-healing lesions; disease susceptibility could also be transferred into naive animals with T cells from non-immune donors. When the ability to mount a delayed-type hypersensitivity (DTH) reaction was tested in these two groups, the high-parasite dose group gave a significantly higher response. The in vivo protection and high DTH response were reflected in the ability of cells derived from the high-dose resistant (but not low-dose susceptible) mice to mount an antigen-specific T cell response in vitro. The possible immunological effector mechanisms underlying high-dose resistance and low-dose susceptibility are discussed.

Entities:  

Mesh:

Year:  1991        PMID: 1864002      PMCID: PMC1535739          DOI: 10.1111/j.1365-2249.1991.tb05710.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Influence of Lsh, H-2, and an H-11-linked gene on visceralization and metastasis associated with Leishmania mexicana infection in mice.

Authors:  M Roberts; J Alexander; J M Blackwell
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

2.  Effect of CD4 monoclonal antibody in vivo on lesion development, delayed-type hypersensitivity and interleukin 3 production in experimental murine cutaneous leishmaniasis.

Authors:  F Y Liew; S Millott; R Lelchuk; S Cobbold; H Waldmann
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

3.  In vitro and in vivo effects of interleukin 2 on the protozoan parasite leishmania.

Authors:  C Mazingue; F Cottrez-Detoeuf; J Louis; M Kweider; C Auriault; A Capron
Journal:  Eur J Immunol       Date:  1989-03       Impact factor: 5.532

4.  Diffuse cutaneous leishmaniasis: a disease due to an immunological defect of the host.

Authors:  J Convit; M E Pinardi; A J Rondón
Journal:  Trans R Soc Trop Med Hyg       Date:  1972       Impact factor: 2.184

5.  Genetic analysis of Leishmania mexicana infection in mice: single gene (Scl-2) controlled predisposition to cutaneous lesion development.

Authors:  M Roberts; J Alexander; J M Blackwell
Journal:  J Immunogenet       Date:  1990 Feb-Apr

6.  Sex differences and cross-immunity in DBA/2 mice infected with L. mexicana and L. major.

Authors:  J Alexander
Journal:  Parasitology       Date:  1988-04       Impact factor: 3.234

7.  The correlation between delayed hypersensitivity, lymphocyte activation and protective immunity in experimental murine leishmaniasis.

Authors:  R A De Rossell; R S Bray; J Alexander
Journal:  Parasite Immunol       Date:  1987-01       Impact factor: 2.280

8.  Recognition of Leishmania donovani antigens by murine T lymphocyte lines and clones. Species cross-reactivity, functional correlates of cell-mediated immunity, and antigen characterization.

Authors:  H W Sheppard; P A Scott; D M Dwyer
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

9.  Quantification of Leishmania-specific T cells in human American cutaneous leishmaniasis (Leishmania braziliensis braziliensis) by limiting dilution analysis.

Authors:  R C Dórea; S G Coutinho; P C Sabroza; J Hendriks; L Cysne; F Conceição-Silva
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

10.  Adoptive transfer of delayed type hypersensitivity reactions specific for Leishmania major antigens to normal mice using murine T cell populations and clones generated in vitro.

Authors:  G C Lima; H D Engers; J A Louis
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.